These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36993233)

  • 21. Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs.
    Ferruz N; Doerr S; Vanase-Frawley MA; Zou Y; Chen X; Marr ES; Nelson RT; Kormos BL; Wager TT; Hou X; Villalobos A; Sciabola S; De Fabritiis G
    Sci Rep; 2018 Jan; 8(1):897. PubMed ID: 29343833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Cryptic Binding Sites Using MixMD with Standard and Accelerated Molecular Dynamics.
    Smith RD; Carlson HA
    J Chem Inf Model; 2021 Mar; 61(3):1287-1299. PubMed ID: 33599485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein Binding Pocket Optimization for Virtual High-Throughput Screening (vHTS) Drug Discovery.
    Gazgalis D; Zaka M; Abbasi BH; Logothetis DE; Mezei M; Cui M
    ACS Omega; 2020 Jun; 5(24):14297-14307. PubMed ID: 32596567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ligand discrimination during virtual screening of the CB1 cannabinoid receptor crystal structures following cross-docking and microsecond molecular dynamics simulations.
    Loo JSE; Emtage AL; Murali L; Lee SS; Kueh ALW; Alexander SPH
    RSC Adv; 2019 May; 9(28):15949-15956. PubMed ID: 35521393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deep Learning and Structure-Based Virtual Screening for Drug Discovery against NEK7: A Novel Target for the Treatment of Cancer.
    Aziz M; Ejaz SA; Zargar S; Akhtar N; Aborode AT; A Wani T; Batiha GE; Siddique F; Alqarni M; Akintola AA
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors.
    Lane JR; Chubukov P; Liu W; Canals M; Cherezov V; Abagyan R; Stevens RC; Katritch V
    Mol Pharmacol; 2013 Dec; 84(6):794-807. PubMed ID: 24021214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity.
    Jaiteh M; Rodríguez-Espigares I; Selent J; Carlsson J
    PLoS Comput Biol; 2020 Mar; 16(3):e1007680. PubMed ID: 32168319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the structural origins of cryptic sites on proteins.
    Beglov D; Hall DR; Wakefield AE; Luo L; Allen KN; Kozakov D; Whitty A; Vajda S
    Proc Natl Acad Sci U S A; 2018 Apr; 115(15):E3416-E3425. PubMed ID: 29581267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding the Accessible Chemical Space of SIRT2 Inhibitors through Exploration of Binding Pocket Dynamics.
    Djokovic N; Ruzic D; Rahnasto-Rilla M; Srdic-Rajic T; Lahtela-Kakkonen M; Nikolic K
    J Chem Inf Model; 2022 May; 62(10):2571-2585. PubMed ID: 35467856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct inactive conformations of the dopamine D2 and D3 receptors correspond to different extents of inverse agonism.
    Lane JR; Abramyan AM; Adhikari P; Keen AC; Lee KH; Sanchez J; Verma RK; Lim HD; Yano H; Javitch JA; Shi L
    Elife; 2020 Jan; 9():. PubMed ID: 31985399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptic-site binding mechanism of medium-sized Bcl-xL inhibiting compounds elucidated by McMD-based dynamic docking simulations.
    Bekker GJ; Fukuda I; Higo J; Fukunishi Y; Kamiya N
    Sci Rep; 2021 Mar; 11(1):5046. PubMed ID: 33658550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein tyrosine phosphatases: Ligand interaction analysis and optimisation of virtual screening.
    Ghattas MA; Atatreh N; Bichenkova EV; Bryce RA
    J Mol Graph Model; 2014 Jul; 52():114-23. PubMed ID: 25038507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and dynamic determinants for highly selective RET kinase inhibition reveal cryptic druggability.
    Shehata MA; Contreras J; Martín-Hurtado A; Froux A; Mohamed HT; El-Sherif AA; Plaza-Menacho I
    J Adv Res; 2023 Mar; 45():87-100. PubMed ID: 35595215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting cryptic-orthosteric site of PD-L1 for inhibitor identification using structure-guided approach.
    Mittal L; Tonk RK; Awasthi A; Asthana S
    Arch Biochem Biophys; 2021 Nov; 713():109059. PubMed ID: 34673001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small-Molecule Allosteric Modulators of the Protein Kinase PDK1 from Structure-Based Docking.
    Rettenmaier TJ; Fan H; Karpiak J; Doak A; Sali A; Shoichet BK; Wells JA
    J Med Chem; 2015 Oct; 58(20):8285-8291. PubMed ID: 26443011
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virtual screening with AutoDock Vina and the common pharmacophore engine of a low diversity library of fragments and hits against the three allosteric sites of HIV integrase: participation in the SAMPL4 protein-ligand binding challenge.
    Perryman AL; Santiago DN; Forli S; Martins DS; Olson AJ
    J Comput Aided Mol Des; 2014 Apr; 28(4):429-441. PubMed ID: 24493410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Divide and Conquer. Pocket-Opening Mixed-Solvent Simulations in the Perspective of Docking Virtual Screening Applications for Drug Discovery.
    Sabanés Zariquiey F; Jacoby E; Vos A; van Vlijmen HWT; Tresadern G; Harvey J
    J Chem Inf Model; 2022 Feb; 62(3):533-543. PubMed ID: 35041430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
    Tang H; Wang XS; Hsieh JH; Tropsha A
    Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-nucleoside Inhibitors of Zika Virus RNA-Dependent RNA Polymerase.
    Gharbi-Ayachi A; Santhanakrishnan S; Wong YH; Chan KWK; Tan ST; Bates RW; Vasudevan SG; El Sahili A; Lescar J
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32796069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.